Schedule 13G ownership disclosure

NEOLEUKIN THERAPEUTICS INC

Security class unavailable · CUSIP: 64049K104

Event date: 2019-12-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,915,880
Percent of class
8.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-19-000673
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Dec 27, 2019
Reporting period
Dec 17, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub